Bldg. 469- 2ND floor refurbishment & infrastructure
Ended Awarded Last action
- Contract number
- HHSN26100021
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,286,721
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $13,286,720.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost No Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $45,383 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $23,428 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $13,217,910 |
Show all 11
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on August 12, 2016, with a ceiling value of $13.3 million for Building 469 second-floor refurbishment and infrastructure work at the Frederick National Laboratory for Cancer Research. The order was issued under cost-no-fee pricing and reached ultimate completion on July 9, 2021.
Place of performance is Frederick, MD. The work encompassed building renovation and infrastructure improvements supporting NCI's Frederick campus operations. Leidos Biomedical Research, a subsidiary of Leidos Holdings Inc., operates the Frederick National Laboratory as an FFRDC contractor for NCI and maintains its primary operational footprint at the Frederick site.
Service Contract Inventory reporting for this order captured $100 thousand invoiced in FY2021 (the order's most recent reporting year before completion), representing 0.2 FTEs across 345 contractor hours. The derived government-paid hourly rate for FY2021 was $289.47/hr. Leidos Biomedical Research self-performed all reported hours without subcontractor engagement on this delivery order.
Quick answers
Who was awarded contract HHSN26100021?
HHSN26100021 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 12, 2016.
How much is contract HHSN26100021 worth?
The government has obligated $13,286,721 on HHSN26100021.
Is contract HHSN26100021 an order under another contract?
Yes. HHSN26100021 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100021 competed?
The extent of competition for HHSN26100021 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award